0001578563-24-000331.txt : 20240716
0001578563-24-000331.hdr.sgml : 20240716
20240716162355
ACCESSION NUMBER: 0001578563-24-000331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240716
DATE AS OF CHANGE: 20240716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doyle Mittie
CENTRAL INDEX KEY: 0001918845
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 241119912
MAIL ADDRESS:
STREET 1: C/O DICE THERAPEUTICS, INC.
STREET 2: 279 E. GRAND AVENUE, SUITE 300, LOBBY B
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-07-15
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001918845
Doyle Mittie
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
12.65
2024-07-15
4
A
0
234000
0
A
2034-07-15
Common Stock
234000
234000
D
Twenty-five percent (25%) of the Option Shares vest on July 15, 2025 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date.
/s/ Donald R. Reynolds, by Power of Attorney
2024-07-16